Poland· PL-100325319

Ligosan

A doxycycline product containing doxycyclinum, registered in Poland by Kulzer GmbH. The same ATC class is registered in 7 of our 19 countries.

ATC A01AB22

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedLigosanATCA01AB22REGISTER NO.PL-100325319PACKS LISTED5CHECKEDSeptember 27, 2026

Where it is registered

Doxycycline is registered in 7 of 19 countries.

Countries holding a registration under ATC A01AB22 (doxycycline), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 4 of them publish a price we can compare per daily dose

Doxycycline · ATC A01AB22

7 / 19 countries

  • Belgiumprice
  • Canada
  • Finlandprice
  • Germany
  • Polandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Doxycyclinum
Manufacturer
Kulzer GmbH
Country
Poland (PL)
ATC code
A01AB22
ATC class
Doxycycline
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 5

  • gtin
    05909991188450
  • gtin
    05909991188467
  • gtin
    05909991188474
  • gtin
    05909991188481
  • gtin
    05909991188498

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

2 interactions on record for doxycycline.

Graded by severity as the source publishes them — 2 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Doxycycline · interactions on record

2 records

  • 2 moderate

Most severe, free to view

  • MethoxsalenL01XD10moderate
  • VerteporfinS01LA01moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Doxycycline in 17 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All doxycycline products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

  • Austria · Doxybene, Doxycyclin G.L
  • Belgium · Doxycycline Eg, Doxycycline Sandoz
  • Bulgaria · Вибрамицин, Доксициклин Tzf
  • Cyprus · Doxat, Medomycin
  • Czechia · Deoxymykoin, Doxybene
  • Germany · Doxakne Tabs, Doxy
  • Denmark · Doxycycline Macure, Oracea
  • Estonia · Adoxtar, Doxy-M
  • Spain · Dosil, Doxiciclina Normon
  • Finland · Doximed, Doximycin
  • France · Doxy, Doxycycline Arrow
  • United Kingdom (Northern Ireland) · Doxycycline, Doxycycline Accord-Uk
  • Greece · Oracea, Smilitene
  • Croatia · Doksiciklin Belupo
  • Hungary · Doxitidin, Doxycyclin Al
  • Ireland · Doxycycline Activase Pharmaceuticals, Doxycycline Athlone Pharmaceuticals
  • Iceland · Doxycyklin Eql Pharma, Doxylin
  • Italy · Bassado, Doxynor
  • Liechtenstein · Ligosan
  • Lithuania · Adoxtar, Doxitin
  • Luxembourg · Doxycycline Eg, Doxycycline Sf Ratiopharm
  • Latvia · Doxitin, Doxy-M
  • Malta · Doxat, Doxycycline Activase
  • Netherlands · Doxycycline Accord, Doxycycline Disp Teva
  • Norway · Doksycyklin Hexal, Doxycycline Macure
  • Portugal · Actidox, Adoxtar
  • Romania · Doxiciclină Arena, Doxiciclina Atb
  • Sweden · Doxycycline Macure, Doxycyklin Eql Pharma
  • Slovenia · Doksivibra
  • Slovakia · Deoxymykoin, Doxyhexal

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/7ac33f5d-790b-437f-bc80-d093820e8090
GET /v1/drugs/7ac33f5d-790b-437f-bc80-d093820e8090?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Żel okołozębowy",
  "source": "urpl",
  "strength": "140 mg/g",
  "packaging": "05909991188450 ¦ Rp ¦ 103786\n8 szt.\n05909991188467 ¦ Rp ¦ 103787\n2 szt.\n05909991188474 ¦ Rp ¦ 103788\n16 szt.\n05909991188481 ¦ Rp ¦ 103789\n10 szt.\n05909991188498 ¦ Rp ¦ 103790\n4 szt.",
  "substance": "Doxycyclini hyclas 161.5 mg/g",
  "common_name": "Doxycyclinum",
  "pl_product_id": "100325319",
  "pozwolenie_nr": "22045",
  "auth_procedure": "DCP",
  "authorisation_validity": "Bezterminowe"
}

See everything about doxycycline.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.